| Original language | English |
|---|---|
| Pages (from-to) | 195-197 |
| Number of pages | 3 |
| Journal | American Heart Journal |
| Volume | 85 |
| Issue number | 2-3 |
| Publication status | Published - 2002 |
Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure?
PR Kalra, J Moon, AJ Coats
Research output: Contribution to journal › Article
272
Citations
(Scopus)